Advance and challenge in research on meningococcal group B vaccines
10.7501/j.issn.1674-6376.2017.08.027
- VernacularTitle:B群脑膜炎球菌疫苗的研究现状及挑战
- Author:
shan Shan WANG
1
;
Qiang YE
Author Information
1. 中国食品药品检定研究院卫生部生物技术产品检定方法及其标准化重点实验室
- Keywords:
meningococcal disease;
meningococcal group B vaccines;
OMV vaccines;
reverse vaccinology;
recombinant vaccines
- From:
Drug Evaluation Research
2017;40(8):1163-1167
- CountryChina
- Language:Chinese
-
Abstract:
It is generally accepted that vaccinations are one of the most effective tool for control of infectious diseases.In recent years,the research on meningococcal group B vaccines has made progress extensively.A new meningococcal group B vaccine,developed by the reverse vaccinology technology,has been approved by the European Medicines Agency and the Food and Drag Administration.Although no related products has been approve till now in China,some meningococcal group B vaccines are also developing in domestic companies and research institutes.Therefore,to further understand these vaccines and facilitate the development of meningococcal group B vaccines,this paper reviews advance and challenge in research on meningococcal group B vaccines.
